Valvulopathies in sub-Saharan African children: patterns, humanitarian interventions and cardiac surgical problems

Maurizio Ferratini1, Stefano Marianeschi, Francesco Santoro

  • 1Don Carlo Gnocchi Foundation, Rehabilitative Cardiology IRCCS Santa Maria Nascente Milan, Italy. mferratini@dongnocchi.it

Insights

Rheumatic valve disease (RVD) is a major health crisis in sub-Saharan Africa, with limited treatment options and high mortality rates in children. This review highlights management challenges and successful international patient transfer programs for RVD care.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Global Health

Background:

  • Rheumatic fever and subsequent rheumatic valve disease (RVD) pose a significant health burden in sub-Saharan Africa, with prevalence 10-20 times higher than in industrialized nations.
  • Over 50% of African RVD patients are estimated to die before age 25, often presenting with severe heart failure and growth retardation.
  • Current strategies for RVD control are insufficient, necessitating a review of clinical and management issues.

Purpose of the Study:

  • To review the clinical presentation and management of RVD in children within the sub-Saharan African context.
  • To discuss the challenges and outcomes of surgical interventions for RVD in resource-limited settings.
  • To evaluate different approaches to managing RVD, including valve repair and prosthetic options, and humanitarian efforts.

Main Methods:

  • Review of clinical and management data for RVD in children in sub-Saharan Africa.
  • Analysis of prevalent clinical presentations, including severe heart failure and undergrowth.
  • Evaluation of surgical strategies: valve repair versus prosthetic implantation (mechanical vs. biologic).

Main Results:

  • Severe mitral regurgitation is the most common valvulopathy in the first two decades of life.
  • Valve repair can have unfavorable outcomes in cases of extreme cardiomegaly.
  • Mechanical mitral prostheses are preferred when anticoagulation is feasible; biologic prostheses are best reserved for situations where anticoagulation is not possible.

Conclusions:

  • Socioeconomic factors severely limit access to cardiac surgery in sub-Saharan Africa.
  • Humanitarian initiatives, including international patient transfers for specialized care, offer a viable solution.
  • Addressing RVD requires comprehensive strategies, improved healthcare access, and innovative management approaches tailored to the region's challenges.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
622
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
589
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
328
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
810